NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom, Inc." or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom, Inc. investors who were adversely affected by alleged securities fraud between January 8, 2024 and September 17, 2025.

DUBLIN, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with a leading bioinformatics company to conduct advanced analysis on clinical trial data for EpiCapture, the company's PCR-based epigenetic liquid biopsy test for monitoring the risk of prostate cancer progressing to more aggressive forms of the disease.

MIAMI, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Safe and Green Development Corporation (NASDAQ: SGD) (“SGD,” the “Company,” or “Safe and Green Development”) today announced financial results for the three and nine months ended September 30, 2025, highlighted by record quarterly revenue growth, margin expansion, and continued operational momentum across engineered soils, and logistics divisions.

BENSALEM, Pa. , Nov. 13, 2025 /PRNewswire/ -- The Law Offices of Howard G.

LOS ANGELES , Nov. 13, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Quanex Building Products Corporation ("Quanex" or the "Company") (NYSE: NX). IF YOU SUFFERED A LOSS ON YOUR QUANEX INVESTMENTS, CLICK HERE BEFORE NOVEMBER 18, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

BENSALEM, Pa. , Nov. 13, 2025 /PRNewswire/ -- The Law Offices of Howard G.

BENSALEM, Pa. , Nov. 13, 2025 /PRNewswire/ -- The Law Offices of Howard G.

LOS ANGELES , Nov. 13, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ: JSPR) have opportunity to lead the securities fraud class action lawsuit.

LOS ANGELES , Nov. 13, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to KBR, Inc. ("KBR" or the "Company") (NYSE: KBR) have opportunity to lead the securities fraud class action lawsuit.

LOS ANGELES , Nov. 13, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to RCI Hospitality Holdings, Inc. ("RCI" or the "Company") (NASDAQ: RICK) have opportunity to lead the securities fraud class action lawsuit.

Stifel Financial Corp. ( SF ) Wolfe Wealth Symposium 2026 November 13, 2025 1:15 PM EST Company Participants Ronald J. Kruszewski - Chairman & CEO James Marischen - Senior VP & CFO Conference Call Participants Steven Chubak - Wolfe Research, LLC Presentation Steven Chubak Wolfe Research, LLC Good afternoon to everybody in the room as well as those of you on the webcast.

New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your KBR, Inc. (NYSE: KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=177269&wire=5&utm_campaign=3 or contact Joseph E. Levi, Esq.

Memory chip stocks are deep in the red today, after Japanese peer Kioxia's earnings and revenue were dismally short of estimates.

New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your DexCom, Inc. (NASDAQ: DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=177268&wire=5&utm_campaign=17 or contact Joseph E. Levi, Esq.

CRISPR Therapeutics AG remains a pioneering gene editing company, with Casgevy's slow commercial ramp and robust pipeline driving long-term potential. Despite Casgevy's $2.2M list price and broad approvals, revenue growth is gradual due to complex treatment logistics and patient adoption hurdles. CRSP's pipeline includes promising in-vivo cardiovascular, CAR-T oncology/autoimmune, and diabetes programs, with key updates expected in 2025.

LOS ANGELES , Nov. 13, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ: SNPS) have opportunity to lead the securities fraud class action lawsuit.

Ideal Power Inc. ( IPWR ) Q3 2025 Earnings Call November 13, 2025 10:00 AM EST Company Participants Jeff Christensen David Somo - CEO, President & Director Timothy Burns - CFO, Secretary & Treasurer Conference Call Participants Casey Ryan - WestPark Capital, Inc., Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Ideal Power Third Quarter 2025 Results Conference Call. [Operator Instructions] As a reminder, this event is being recorded.

Tecogen Inc. ( TGEN ) Q3 2025 Earnings Call November 13, 2025 9:30 AM EST Company Participants John Whiting - General Counsel & Secretary Abinand Rangesh - CEO & Director Roger Deschenes - CFO, Treasurer & Chief Accounting Officer Conference Call Participants Alfred Moore - ROTH Capital Partners, LLC, Research Division Alexander Blanton - Clear Harbor Asset Management, LLC Barry Hymes Presentation Operator Greetings. Welcome to the Tecogen Third Quarter 2025 Conference Call.

Okeanis Eco Tankers Corp. ( ECO ) Q3 2025 Earnings Call November 13, 2025 7:30 AM EST Company Participants Iraklis Sbarounis - Chief Financial Officer Aristidis Alafouzos - Chief Executive Officer Conference Call Participants Frode Morkedal - Clarksons Platou Securities, Inc., Research Division Omar Nokta - Jefferies LLC, Research Division Liam Burke - B. Riley Securities, Inc., Research Division Climent Molins - Value Investor's Edge Presentation Operator Welcome to OET's Third Quarter 2025 Financial Results Presentation.

Cellectar Biosciences, Inc. ( CLRB ) Q3 2025 Earnings Call November 13, 2025 8:30 AM EST Company Participants James Caruso - President, CEO & Director Chad Kolean - VP, CFO & Secretary Jarrod Longcor - Chief Operating Officer Conference Call Participants Anne Marie Fields Aydin Huseynov - Ladenburg Thalmann & Co. Inc., Research Division Jeffrey Jones - Oppenheimer & Co. Inc., Research Division Jonathan Aschoff - ROTH Capital Partners, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November …